Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 71 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
701 14.8 months Metastatic colorectal cancer 4 Chemotherapy
University of Oxford United Kingdom 2/2003
Treatment Details: Patients: 290 patients with colorectal cancer with metastases confined to the liver were involved in this study. Patients were divided into two groups: an intrahepatic treatment group comp
 
702 14.8 months Malignant Pleural Mesothelioma 4 Chemotherapy
Newcastle General Hospital United Kingdom 8/2002
Treatment Details: Patients: This Phase I study involved 27 patients with malignant pleural mesothelioma. None of these patients had received prior chemotherapy. Treatment: The treatment consisted of two c
 
703 14.8 months Stage III NSCLC 5 Chemotherapy
Radiation
University of Chicago Medical Center United States 10/2002
Treatment Details: Patients: This Phase II study involved a total of 175 patients with stage III non-small cell lung cancer. Patients were divided into three groups. Group A contained 62 patients. Group B c
 
704 14.8 months metastatic colorectal cancer 4 Chemotherapy
University of Oxford United Kingdom 2/2003
Treatment Details: Patients: 290 patients with colorectal cancer with metastases confined to the liver were involved in this study. Patients were divided into two groups: an intrahepatic treatment group comp
 
705 14.8 months advanced melanoma 4 Immunotherapy
University of Virginia United States 1/2003
Treatment Details: Patients: This Phase II study involved 26 patients with advanced melanoma. Patients were divided into two groups of 13 patients each - Group A and Group B. There were 6 men and 7 women in
 
706 14.8 months Advanced malignant mesothelioma 5 Biologic therapy
Chemotherapy
University of Texas Southwestern Medical Center United States 9/2012
Treatment Details: Patients: This phase II study involved 53 previously untreated patients with advanced malignant mesothelioma. The median patient age was 66 years and 85% were male. Treatment: Patients
 
707 14.8 months Malignant Pleural Mesothelioma 4 Biologic therapy
Chemotherapy
National Cancer Institute United States 12/2014
Treatment Details: Patients: This phase 2 study involved 89 malignant pleural mesothelioma patients. The median patient age was 67 years and 78% were male. Treatment: Patients received chemotherapy with
 
708 14.7 months Malignant mesothelioma 4 Chemotherapy
University of Chicago Comprehensive Cancer Center United States 6/2012
Treatment Details: Patients: This phase II study involved malignant mesothelioma patients who were divided into two separate treatment groups. Group A consisted of 53 patients with a median age of 62 years;
 
709 14.7 months Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Royal Marsden Hospital United Kingdom 11/2005
Treatment Details: Patients: This Phase III study involved 630 patients with previously untreated metastatic colorectal cancer. The patients were randomized into two groups. Group A had 422 patients (257 men
 
710 14.7 months Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Royal Marsden Hospital United Kingdom 11/2005
Treatment Details: Patients: This Phase III study involved 630 patients with previously untreated metastatic colorectal cancer. The patients were randomized into two groups. Group A had 422 patients (257 men
 
Page 71 of 187  | Previous Page  | Next Page